COMMUNIQUÉS West-GlobeNewswire

AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis

28/05/2018 - 18:24

Paris, May 28, 2018, 6.15pm AB Science provides update on EU marketing authorization application for masitinib in the treatment of amyotrophic lateral sclerosis AB Science SA (NYSE Euronext - FR0010557264 - AB), a [...]

AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique

28/05/2018 - 18:24

Paris, 28 mai 2018, 18h15 AB Science fait le point sur la demande d'autorisation de mise sur le marché du masitinib dans le traitement de la sclérose latérale amyotrophique AB Science SA (NYSE Euronext - FR0010557264 - [...]

Ossur Hf :Transactions in relation to share buyback program

28/05/2018 - 18:01

Announcement no. 37/2018 Reykjavik, 28 May 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the [...]

NÉOVACS : COMPTE-RENDU ASSEMBLÉE GÉNÉRALE ANNUELLE 2018

28/05/2018 - 18:01

COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE · COMMUNIQUÉ DE PRESSE COMPTE-RENDU ASSEMBL É E G É N É RALE ANNUELLE 2018 ACTIVATION DE LA DERNI È RE TRANCHE DE LA LIGNE DE FINANCEMENT EN FONDS PROPRES EXISTANTE, [...]

Share buy-back week 21/2018

28/05/2018 - 16:41

Announcement 28 May 2018 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 3/2018 Coloplast has initiated the first part of the share buy-back programme totalling up [...]

Novartis International AG: Patient-reported outcomes tool revealed significant improvement in symptom frequency and quality of life domains with Entresto®

28/05/2018 - 16:31

Overall summary score was also significantly higher for Entresto patients than for patients not taking Entresto, as measured by the 12-item Kansas City Cardiomyopathy Questionnaire (KCCQ-12)[1] These improvements were [...]

Aurora Spine Corporation Files Condensed Consolidated Financial Statements for the Three Months Ended March 31, 2018

28/05/2018 - 15:01

NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., May 28, 2018 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV:ASG) announces financial [...]

Novo Nordisk A/S - Share repurchase programme

28/05/2018 - 12:52

Bagsværd, Denmark, 28 May 2018 - On 4 May 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 (MAR), [...]

Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia

28/05/2018 - 11:20

Company Announcement - No. 16/2018 Zealand Pharma reports completion of the second and pivotal Phase 3 trial with dasiglucagon for the treatment of severe hypoglycemia Last patient visit concluded in the multinational [...]

Mandatory notification of trade

28/05/2018 - 10:42

Reference is made to the announcement today from Vistin Pharma ASA ("Vistin Pharma") regarding the final result of the subsequent repair issue. Vegard Heggem, VP Operations, has been allocated 10,000 new shares at a [...]

Transactions under Novozymes’ stock buyback program

28/05/2018 - 10:34

Please read the full announcement in the attached PDF Attachment 2018_36_Stock_Buybackprogram_EN

Announcement by Heirs of Late Valerijs Maligins

28/05/2018 - 09:03

Announcement by Heirs of Late Valerijs Maligins JSC Olainfarm hereby informs that it has received the folowing announcement from heirs of Valerijs Maligins. Mutually Acceptable Agreement is Reached About Distribution of [...]

Solon Eiendom ASA : Primary insider notification

28/05/2018 - 08:31

(Oslo, Norway, May 25, 2018) Solon Eiendom ASA Board Member Tore Aksel Voldberg (through his wholly owned company Dukat AS) has today bought 30.000 shares in Solon Eiendom ASA at a price of NOK 28.7105. Following this [...]

Solon Eiendom ASA : Commencement of subscription period

28/05/2018 - 08:31

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

PCI Biotech: Disclosure of voting rights for Chairman of the Board

28/05/2018 - 08:31

Oslo, 28 May 2018. PCI Biotech Holding ASA ("PCI Biotech" or the "Company") issue this notification on behalf of its chairman, Hans Peter Bøhn. Hans Peter Bøhn is chairman of PCI Biotech and shall open the annual [...]

Vistin Pharma ASA : Final result of the subsequent repair issue

28/05/2018 - 08:24

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA OR JAPAN, OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR [...]

Shire plc : Rule 2.9 Announcement

28/05/2018 - 08:00

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION. 28 May 2018 Shire [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

28/05/2018 - 07:06

REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

28/05/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 28 May 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]